- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有384家主力机构披露2025-12-31报告期持股数据，持仓量总计2.78亿股，占流通A股19.68%
- 波段诊断：
-
技术面诊股
平均成本
近期的平均成本为12.59元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"12.59","date":1780473804,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2026.06.04","stock":"-3.26","trade":"-1.92","ind":"-0.27"},{"date":"2026.06.03","stock":"-3.38","trade":"-1.41","ind":"0.73"},{"date":"2026.06.02","stock":"-2.70","trade":"-1.97","ind":"1.63"},{"date":"2026.06.01","stock":"0.81","trade":"-0.39","ind":"-1.51"},{"date":"2026.05.29","stock":"-0.88","trade":"0.05","ind":"-1.81"},{"date":"2026.05.28","stock":"-0.51","trade":"-0.93","ind":"0.80"},{"date":"2026.05.27","stock":"2.99","trade":"-1.64","ind":"-0.88"},{"date":"2026.05.26","stock":"-2.26","trade":"-1.38","ind":"0.12"},{"date":"2026.05.25","stock":"-2.63","trade":"-0.08","ind":"1.66"},{"date":"2026.05.22","stock":"-2.97","trade":"-0.82","ind":"2.30"},{"date":"2026.05.21","stock":"-1.70","trade":"-0.59","ind":"-2.07"},{"date":"2026.05.20","stock":"-1.27","trade":"-0.82","ind":"0.00"},{"date":"2026.05.19","stock":"0.88","trade":"0.76","ind":"0.26"},{"date":"2026.05.18","stock":"-1.60","trade":"-1.13","ind":"-0.20"},{"date":"2026.05.15","stock":"-0.33","trade":"-0.86","ind":"-1.17"},{"date":"2026.05.14","stock":"-3.27","trade":"-2.00","ind":"-2.14"},{"date":"2026.05.13","stock":"-1.27","trade":"-0.69","ind":"1.67"},{"date":"2026.05.12","stock":"-3.95","trade":"-1.53","ind":"-0.47"},{"date":"2026.05.11","stock":"6.33","trade":"3.08","ind":"2.16"},{"date":"2026.05.08","stock":"0.59","trade":"0.41","ind":"-0.50"},{"date":"2026.05.07","stock":"-0.19","trade":"0.68","ind":"1.18"}]
智飞生物,深证成指,生物制品指数
压力支撑
该股压力位为12.59元，支撑位为12.25元。
[{"text":"\u538b\u529b\u4f4d","value":"12.59","date":1780502400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.25","date":1780502400,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.3资金面打败了28%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月05日 08:07
| 机构今日流向(万元) | -1591.12 | 机构5日流向(万元) | -4692.82 |
| 机构10日流向(万元) | -13351.55 | 机构20日流向(万元) | -28424.66 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少988.64万股，其中基金净减仓182家，主力净减仓10家，请投资者中长期谨慎为宜。
截止2025-12-31，共384家主力机构（基金381家，社保基金1家，一般法人2家），持仓量总计27835.09万股，占流通A股19.68%
其中，基金持仓与2025-06-30相比：
增仓：60家 ，增持 1497.80万股
减仓：242家 ，减持 3641.16万股
新出现在主力名单中：60家 ，持有2089.95万股
从主力名单中消失：70家 ，原持有415.35万股
其中，基金持仓与2025-06-30相比：
增仓：60家 ，增持 1497.80万股
减仓：242家 ，减持 3641.16万股
新出现在主力名单中：60家 ，持有2089.95万股
从主力名单中消失：70家 ，原持有415.35万股
消息面诊股
诊断结果：4.4消息面打败了0%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 智飞生物：6月3日获融资买入2100.58万元
2026-06-04 - 智飞生物：公司目前不存在实施退市风险警示或其他风险
2026-06-03 - 智飞生物：6月2日获融资买入1595.87万元
2026-06-03 - 智飞生物：6月1日获融资买入1052.79万元
2026-06-02 - 【直击智飞生物股东会】 董事长蒋仁生：坚持“自研+
2026-06-01 - 智飞生物：5月29日获融资买入1972.84万元
2026-06-01 - 智飞生物：公司员工持股计划正常存续中
2026-05-29 - 智飞生物：司美格鲁肽（降糖）已经完成Ⅲ期临床试验
2026-05-29 - 智飞生物：公司持续加快产品创新推动在研管线进展
2026-05-29 - 行业周报|生物制品指数跌-3.93%, 跑输上证指
2026-05-29
消息列表
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-05-08 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-17 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-12 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-05 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-18 |
| 一般消息 | 高管变动 | 因公司治理结构及内部工作调整 | 2025-10-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-19 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：4.7行业面打败了68%的股票
生物制品行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2026.06.04","price":"-0.27","value":"-1.92"},{"date":"2026.06.03","price":"0.73","value":"-1.41"},{"date":"2026.06.02","price":"1.63","value":"-1.97"},{"date":"2026.06.01","price":"-1.51","value":"-0.39"},{"date":"2026.05.29","price":"-1.81","value":"0.05"},{"date":"2026.05.28","price":"0.80","value":"-0.93"},{"date":"2026.05.27","price":"-0.88","value":"-1.64"},{"date":"2026.05.26","price":"0.12","value":"-1.38"},{"date":"2026.05.25","price":"1.66","value":"-0.08"},{"date":"2026.05.22","price":"2.30","value":"-0.82"},{"date":"2026.05.21","price":"-2.07","value":"-0.59"},{"date":"2026.05.20","price":"0.00","value":"-0.82"},{"date":"2026.05.19","price":"0.26","value":"0.76"},{"date":"2026.05.18","price":"-0.20","value":"-1.13"},{"date":"2026.05.15","price":"-1.17","value":"-0.86"},{"date":"2026.05.14","price":"-2.14","value":"-2.00"},{"date":"2026.05.13","price":"1.67","value":"-0.69"},{"date":"2026.05.12","price":"-0.47","value":"-1.53"},{"date":"2026.05.11","price":"2.16","value":"3.08"},{"date":"2026.05.08","price":"-0.50","value":"0.41"},{"date":"2026.05.07","price":"1.18","value":"0.68"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 四环生物 | 23.39% | 2.25% | 5.7分 |
| 2 | 派林生物 | 9.93% | 1.74% | 6.0分 |
| 3 | 双成药业 | 5.63% | -11.88% | 5.4分 |
| 4 | 赛伦生物 | 2.13% | -0.27% | 4.8分 |
| 5 | 特宝生物 | -3.67% | -1.76% | 5.6分 |
| 6 | 博雅生物 | -5.78% | 5.98% | 5.0分 |
| 8 | 卫光生物 | -6.30% | -5.25% | 5.0分 |
| 10 | 安科生物 | -7.38% | -0.75% | 5.3分 |
| 12 | 西藏药业 | -8.06% | -0.40% | 4.5分 |
| 14 | 甘李药业 | -8.94% | 3.19% | 5.5分 |
| 16 | 沃森生物 | -9.35% | -10.31% | 4.9分 |
| 18 | 通化东宝 | -10.00% | 1.72% | 5.4分 |
| 20 | 康辰药业 | -11.34% | -11.11% | 5.4分 |
| 22 | 康弘药业 | -12.00% | 3.79% | 5.5分 |
| 24 | 诺唯赞 | -12.15% | -10.26% | 5.5分 |
| 26 | 优宁维 | -12.91% | -3.70% | 4.4分 |
| 28 | 博晖创新 | -13.59% | -4.98% | 4.9分 |
| 30 | 华兰疫苗 | -13.96% | -5.11% | 4.6分 |
| 32 | 百奥泰 | -14.36% | -8.20% | 5.1分 |
| 34 | 金迪克 | -15.87% | -9.53% | 4.5分 |
| 36 | 康泰生物 | -17.17% | -6.04% | 4.2分 |
| 38 | 赛升药业 | -17.77% | 1.26% | 4.0分 |
| 40 | 智飞生物 | -18.99% | -9.12% | 3.9分 |
| 42 | 诺诚健华 | -19.32% | -10.84% | 4.4分 |
| 44 | 长春高新 | -21.97% | -6.71% | 4.7分 |
| 46 | 近岸蛋白 | -22.31% | -11.05% | 4.4分 |
| 48 | 三生国健 | -22.87% | -4.00% | 5.0分 |
| 50 | 君实生物 | -23.46% | -7.49% | 4.2分 |
| 52 | 迈威生物 | -24.31% | -11.96% | 4.1分 |
| 54 | - | -35.18% | -42.08% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，两项指标的行业排名分别为 45/70 ， 45/70。
[{"date":"2026-03-31","value":"-2.48","vol":"-2.96"},{"date":"2025-12-31","value":"-63.06","vol":"-8.40"},{"date":"2025-09-30","value":"-4.42","vol":"-10.09"},{"date":"2025-06-30","value":"-1.96","vol":"-0.67"},{"date":"2025-03-31","value":"-1.05","vol":"0.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.48 | -63.06 | -4.42 | -1.96 | -1.05 |
| 行业(%) | -2.96 | -8.40 | -10.09 | -0.67 | 0.44 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"29.16","vol":"61.64"},{"date":"2025-12-31","value":"7.84","vol":"66.98"},{"date":"2025-09-30","value":"21.82","vol":"67.71"},{"date":"2025-06-30","value":"28.30","vol":"67.98"},{"date":"2025-03-31","value":"32.01","vol":"69.02"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
29.16 | 7.84 | 21.82 | 28.30 | 32.01 |
| 行业(%) | 61.64 | 66.98 | 67.71 | 67.98 | 69.02 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 36/70 ， 27/70。
[{"date":"2026-03-31","value":"-8.64","vol":"16.15"},{"date":"2025-12-31","value":"-65.61","vol":"35.93"},{"date":"2025-09-30","value":"-66.45","vol":"45.81"},{"date":"2025-06-30","value":"-73.05","vol":"7037.48"},{"date":"2025-03-31","value":"-79.39","vol":"6245.21"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-8.64 | -65.61 | -66.45 | -73.05 | -79.39 |
| 行业(%) | 16.15 | 35.93 | 45.81 | 7037.48 | 6245.21 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-18.79","vol":"74.78"},{"date":"2025-12-31","value":"-846.42","vol":"34.78"},{"date":"2025-09-30","value":"-162.57","vol":"45.67"},{"date":"2025-06-30","value":"-126.62","vol":"5.32"},{"date":"2025-03-31","value":"-121.91","vol":"-8.96"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-18.79 | -846.42 | -162.57 | -126.62 | -121.91 |
| 行业(%) | 74.78 | 34.78 | 45.67 | 5.32 | -8.96 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 19/70 ， 11/70。
[{"date":"2026-03-31","value":"0.07","vol":"0.06"},{"date":"2025-12-31","value":"0.22","vol":"0.30"},{"date":"2025-09-30","value":"0.16","vol":"0.21"},{"date":"2025-06-30","value":"0.10","vol":"0.14"},{"date":"2025-03-31","value":"0.05","vol":"0.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.07 | 0.22 | 0.16 | 0.10 | 0.05 |
| 行业(次) | 0.06 | 0.30 | 0.21 | 0.14 | 0.06 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.36","vol":"0.29"},{"date":"2025-12-31","value":"0.61","vol":"1.30"},{"date":"2025-09-30","value":"0.28","vol":"0.90"},{"date":"2025-06-30","value":"0.16","vol":"0.56"},{"date":"2025-03-31","value":"0.07","vol":"0.26"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.36 | 0.61 | 0.28 | 0.16 | 0.07 |
| 行业(次) | 0.29 | 1.30 | 0.90 | 0.56 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"12.93","vol":"-71.66"},{"date":"2025-12-31","value":"166.07","vol":"12.85"},{"date":"2025-09-30","value":"52.25","vol":"0.21"},{"date":"2025-06-30","value":"49.00","vol":"-1404.66"},{"date":"2025-03-31","value":"12.93","vol":"-47.97"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 12.93 | 166.07 | 52.25 | 49.00 | 12.93 |
| 行业 | -71.66 | 12.85 | 0.21 | -1404.66 | -47.97 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.16","vol":"1.77"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.00","vol":"1.58"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.16 | - | 1.00 | - |
| 行业 | 0.00 | 1.77 | 0.00 | 1.58 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 18/70 ， 23/70。
[{"date":"2026-03-31","value":"3.14","vol":"6.75"},{"date":"2025-12-31","value":"1.53","vol":"5.88"},{"date":"2025-09-30","value":"2.78","vol":"6.07"},{"date":"2025-06-30","value":"2.45","vol":"6.70"},{"date":"2025-03-31","value":"2.30","vol":"7.82"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.14 | 1.53 | 2.78 | 2.45 | 2.30 |
| 行业 | 6.75 | 5.88 | 6.07 | 6.70 | 7.82 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"2.43","vol":"5.22"},{"date":"2025-12-31","value":"1.12","vol":"4.49"},{"date":"2025-09-30","value":"1.21","vol":"4.89"},{"date":"2025-06-30","value":"1.06","vol":"5.34"},{"date":"2025-03-31","value":"1.03","vol":"6.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.43 | 1.12 | 1.21 | 1.06 | 1.03 |
| 行业 | 5.22 | 4.49 | 4.89 | 5.34 | 6.40 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，两项指标的行业排名分别为 8/70 ， 13/70。
[{"date":"2026-03-31","value":"45.99","vol":"27.44"},{"date":"2025-12-31","value":"49.22","vol":"27.58"},{"date":"2025-09-30","value":"36.42","vol":"28.02"},{"date":"2025-06-30","value":"34.18","vol":"26.70"},{"date":"2025-03-31","value":"36.85","vol":"26.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
45.99 | 49.22 | 36.42 | 34.18 | 36.85 |
| 行业(%) | 27.44 | 27.58 | 28.02 | 26.70 | 26.06 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.87","vol":"1.46"},{"date":"2025-12-31","value":"0.99","vol":"1.28"},{"date":"2025-09-30","value":"0.58","vol":"0.58"},{"date":"2025-06-30","value":"0.52","vol":"1.13"},{"date":"2025-03-31","value":"0.58","vol":"0.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.87 | 0.99 | 0.58 | 0.52 | 0.58 |
| 行业(%) | 1.46 | 1.28 | 0.58 | 1.13 | 0.79 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"75.39","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"81.08","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"20.06","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-147.23","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"-12.52","blueLineValue":"-0.52","type":"YC"}]